These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 7677823)
1. Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy. DeGroot LJ; Gorman CA; Pinchera A; Bartalena L; Marcocci C; Wiersinga WM; Prummel MF; Wartofsky L; Marocci C [corrected to Marcocci C] J Clin Endocrinol Metab; 1995 Feb; 80(2):339-40. PubMed ID: 7677823 [No Abstract] [Full Text] [Related]
2. Therapeutic controversies. Summation, commentary, and overview: concerns over aggravation of Graves' ophthalmopathy by radioactive iodine treatment and the use of retrobulbar radiation therapy. Wartofsky L J Clin Endocrinol Metab; 1995 Feb; 80(2):347-9. PubMed ID: 7852488 [No Abstract] [Full Text] [Related]
9. Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy. Wiersinga WM; Smit T; Schuster-Uittenhoeve AL; van der Gaag R; Koornneef L Ophthalmologica; 1988; 197(2):75-84. PubMed ID: 3186212 [TBL] [Abstract][Full Text] [Related]
20. Does radioiodine cause the ophthalmopathy of Graves' disease? McDougall IR Nucl Med Commun; 1993 Feb; 14(2):79-81. PubMed ID: 8429998 [No Abstract] [Full Text] [Related] [Next] [New Search]